Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 64

    1.

    A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding.

    Ko ER, Ko D, Chen C, Lipsick JS.

    Mol Cancer. 2008 Oct 7;7:77.PMID: 18840288 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Epigenetic regulation of gene expression by Drosophila Myb and E2F2-RBF via the Myb-MuvB/dREAM complex.

    Wen H, Andrejka L, Ashton J, Karess R, Lipsick JS.

    Genes Dev. 2008 Mar 1;22(5):601-14.PMID: 18316477 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Loss of Drosophila Myb interrupts the progression of chromosome condensation.

    Manak JR, Wen H, Van T, Andrejka L, Lipsick JS.

    Nat Cell Biol. 2007 May;9(5):581-7. Epub 2007 Apr 22.PMID: 17450131 [PubMed - indexed for MEDLINE]Related articles

    4.

    Myb proteins inhibit fibroblast transformation by v-Rel.

    Fu SL, Ganter B, Lipsick JS.

    Mol Cancer. 2006 Nov 2;5:54.PMID: 17081304 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    v-Myb represses the transcription of Ets-2.

    Wang DM, Sevcikova S, Wen H, Roberts S, Lipsick JS.

    Oncogene. 2007 Feb 22;26(8):1238-44. Epub 2006 Aug 14.PMID: 16909100 [PubMed - indexed for MEDLINE]Related articles

    6.

    synMuv verite--Myb comes into focus.

    Lipsick JS.

    Genes Dev. 2004 Dec 1;18(23):2837-44. Review. No abstract available. PMID: 15574590 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes.

    Davidson CJ, Tirouvanziam R, Herzenberg LA, Lipsick JS.

    Genetics. 2005 Jan;169(1):215-29. Epub 2004 Oct 16.PMID: 15489525 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fluorescence-activated cell sorting (FACS) of Drosophila hemocytes reveals important functional similarities to mammalian leukocytes.

    Tirouvanziam R, Davidson CJ, Lipsick JS, Herzenberg LA.

    Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2912-7. Epub 2004 Feb 19.PMID: 14976247 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Role for a Drosophila Myb-containing protein complex in site-specific DNA replication.

    Beall EL, Manak JR, Zhou S, Bell M, Lipsick JS, Botchan MR.

    Nature. 2002 Dec 19-26;420(6917):833-7.PMID: 12490953 [PubMed - indexed for MEDLINE]Related articles

    10.

    Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability.

    Manak JR, Mitiku N, Lipsick JS.

    Proc Natl Acad Sci U S A. 2002 May 28;99(11):7438-43.PMID: 12032301 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mutational analysis of the transcriptional activation domains of v-Myb.

    Wang DM, Lipsick JS.

    Oncogene. 2002 Feb 28;21(10):1611-5.PMID: 11896590 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Functional evolution of the Myb oncogene family.

    Lipsick JS, Manak J, Mitiku N, Chen CK, Fogarty P, Guthrie E.

    Blood Cells Mol Dis. 2001 Mar-Apr;27(2):456-8.PMID: 11259167 [PubMed - indexed for MEDLINE]Related articles

    13.

    BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.

    Ladendorff NE, Wu S, Lipsick JS.

    Oncogene. 2001 Jan 4;20(1):125-32.PMID: 11244510 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Transcriptional activation by the myb proteins requires a specific local promoter structure.

    Ganter B, Chao ST, Lipsick JS.

    FEBS Lett. 1999 Nov 5;460(3):401-10. Review.PMID: 10556506 [PubMed - indexed for MEDLINE]Related articles

    15.

    Transformation by v-Myb.

    Lipsick JS, Wang DM.

    Oncogene. 1999 May 13;18(19):3047-55. Review.PMID: 10378700 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    Functional analysis of carboxy-terminal deletion mutants of c-Myb.

    Wang DM, Dubendorff JW, Woo CH, Lipsick JS.

    J Virol. 1999 Jul;73(7):5875-86.PMID: 10364339 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Myb and oncogenesis.

    Ganter B, Lipsick JS.

    Adv Cancer Res. 1999;76:21-60. Review. No abstract available. PMID: 10218098 [PubMed - indexed for MEDLINE]Related articles

    19.
    20.

    Myb-related Schizosaccharomyces pombe cdc5p is structurally and functionally conserved in eukaryotes.

    Ohi R, Feoktistova A, McCann S, Valentine V, Look AT, Lipsick JS, Gould KL.

    Mol Cell Biol. 1998 Jul;18(7):4097-108. Erratum in: Mol Cell Biol 1998 Oct;18(10):6164. PMID: 9632794 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.

    Ganter B, Fu S, Lipsick JS.

    EMBO J. 1998 Jan 2;17(1):255-68.PMID: 9427759 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Myb binding sites within the N-ras promoter repress transcription.

    Ganter B, Lipsick JS.

    Oncogene. 1997 Jul 10;15(2):193-202.PMID: 9244354 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.

    Engelke U, Wang DM, Lipsick JS.

    J Virol. 1997 May;71(5):3760-6.PMID: 9094651 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    FAETL motif required for leukemic transformation by v-Myb.

    Fu SL, Lipsick JS.

    J Virol. 1996 Aug;70(8):5600-10.PMID: 8764074 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    One billion years of Myb.

    Lipsick JS.

    Oncogene. 1996 Jul 18;13(2):223-35. Review.PMID: 8710361 [PubMed - indexed for MEDLINE]Related articles

    27.

    Dissociation of transcriptional activation and oncogenic transformation by v-Myb.

    Chen RH, Fields S, Lipsick JS.

    Oncogene. 1995 Nov 2;11(9):1771-9.PMID: 7478605 [PubMed - indexed for MEDLINE]Related articles

    28.

    By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain.

    Engelke U, Smarda J, Lipsick JS.

    Oncogene. 1995 Aug 17;11(4):735-41.PMID: 7651737 [PubMed - indexed for MEDLINE]Related articles

    29.

    Weak transcriptional activation is sufficient for transformation by v-Myb.

    Engelke U, Whittaker L, Lipsick JS.

    Virology. 1995 Apr 20;208(2):467-77.PMID: 7747419 [PubMed - indexed for MEDLINE]Related articles

    30.

    Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.

    Dini PW, Eltman JT, Lipsick JS.

    J Virol. 1995 Apr;69(4):2515-24.PMID: 7884901 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts.

    Smarda J, Lipsick JS.

    Oncogene. 1994 Jan;9(1):237-45.PMID: 8302585 [PubMed - indexed for MEDLINE]Related articles

    33.

    Dicistronic selection for nuclear proteins in living animal cells.

    Smarda J, Lipsick JS.

    Gene. 1993 Dec 27;137(1):145-9.PMID: 8282197 [PubMed - indexed for MEDLINE]Related articles

    34.

    Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo.

    Dini PW, Lipsick JS.

    Mol Cell Biol. 1993 Dec;13(12):7334-48.PMID: 8246954 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Individual repeats of Drosophila Myb can function in transformation by v-Myb.

    Bin X, Lipsick JS.

    J Virol. 1993 Dec;67(12):7332-9.PMID: 8230457 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.

    Aziz N, Wu J, Dubendorff JW, Lipsick JS, Sturgill TW, Bender TP.

    Oncogene. 1993 Aug;8(8):2259-65.PMID: 8336948 [PubMed - indexed for MEDLINE]Related articles

    37.

    Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

    Chen RH, Lipsick JS.

    Mol Cell Biol. 1993 Jul;13(7):4423-31.PMID: 8321242 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans.

    Dubendorff JW, Whittaker LJ, Eltman JT, Lipsick JS.

    Genes Dev. 1992 Dec;6(12B):2524-35.PMID: 1340467 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Protein truncation is not required for c-myb proto-oncogene activity in neuroretina cells.

    Garrido C, Grässer F, Lipsick JS, Stehelin D, Saule S.

    J Virol. 1992 Nov;66(11):6773-6.PMID: 1404616 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation.

    Grässer FA, LaMontagne K, Whittaker L, Stohr S, Lipsick JS.

    Oncogene. 1992 May;7(5):1005-9.PMID: 1570148 [PubMed - indexed for MEDLINE]Related articles

    41.

    Expression of the CD4 gene requires a Myb transcription factor.

    Siu G, Wurster AL, Lipsick JS, Hedrick SM.

    Mol Cell Biol. 1992 Apr;12(4):1592-604.PMID: 1347906 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    The Myb DNA-binding domain is highly conserved in Dictyostelium discoideum.

    Stober-Grässer U, Brydolf B, Bin X, Grässer F, Firtel RA, Lipsick JS.

    Oncogene. 1992 Mar;7(3):589-96.PMID: 1549373 [PubMed - indexed for MEDLINE]Related articles

    43.

    Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

    Garrido C, Leprince D, Lipsick JS, Stehelin D, Gospodarowicz D, Saule S.

    J Virol. 1992 Jan;66(1):160-6.PMID: 1727478 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Protein truncation is required for the activation of the c-myb proto-oncogene.

    Grässer FA, Graf T, Lipsick JS.

    Mol Cell Biol. 1991 Aug;11(8):3987-96.PMID: 2072904 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Determinants of sequence-specific DNA-binding by p48v-myb.

    Garcia A, LaMontagne K, Reavis D, Stober-Grässer U, Lipsick JS.

    Oncogene. 1991 Feb;6(2):265-73.PMID: 2000220 [PubMed - indexed for MEDLINE]Related articles

    46.

    trans activation of gene expression by v-myb.

    Ibanez CE, Lipsick JS.

    Mol Cell Biol. 1990 May;10(5):2285-93.PMID: 2325652 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    DNA-binding activity associated with the v-myb oncogene product is not sufficient for transformation.

    Ibanez CE, Garcia A, Stober-Grässer U, Lipsick JS.

    J Virol. 1988 Nov;62(11):4398-402.PMID: 2845150 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Specific amino acid substitutions are not required for transformation by v-myb of avian myeloblastosis virus.

    Stober-Grässer U, Lipsick JS.

    J Virol. 1988 Mar;62(3):1093-6.PMID: 2828660 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    v-myb does not prevent the expression of c-myb in avian erythroblasts.

    Lipsick JS.

    J Virol. 1987 Oct;61(10):3284-7.PMID: 3041047 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...